Fatty Hepatosis in Diabetes

Abdiyev Ilhom  Allayorovich; Berdiyeva Ra’no  Sultanovna; Rajabova Rano  Mamatovna

Abdiyev Ilhom Allayorovich Assistant of the "Department of Internal Diseases, GP Therapy, MFT and Hematology" of the Termiz branch of the Tashkent Medical Academy
Berdiyeva Ra’no Sultanovna Assistant of the "Department of Internal Diseases, GP Therapy, MFT and Hematology" of the Termiz branch of the Tashkent Medical Academy
Rajabova Rano Mamatovna Assistant of the "Department of Internal Diseases, GP Therapy, MFT and Hematology" of the Termiz branch of the Tashkent Medical Academy

Keywords: diabetes, fatty hepatosis, therapy, hepatocyte, spleen, liver, insulin

Abstract

Fatty hepatosis in diabetes affects the clinical course of the disease, causing various liver disorders, including absorption and antitoxic. Sufficient and effective therapy of fatty hepatosis can be considered as one of the tasks of complex treatment of patients with diabetes. In this context, the results of our research summarized in this article can be useful.

References

1. L. I. Geller, L. N. Gladkix, M. V. Gryaznova “Qandli diabet bilan og'rigan bemorlarda yog'li jigarni davolash” 39-jild, No 5 (1993)
2. Xarikrashna B. Bhatt va Robert J. Smit “Qandli diabetda yog'li jigar kasalligi” 2015 yil aprel; 4(2): 101–108.
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063173/
4. https://remedium.ru/doctor/endocrinology/sakharnyy-diabet-i-nealkogolnaya-bolezn-pecheni/